Stockscreener 앱 받기
4.15
4.60%
-0.20
Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스
What drives Perspective Therapeutics Inc. stock priceBreakthrough financial growth - PrintWeekIndia
What institutions are buying Perspective Therapeutics Inc. stock nowFree Predictions - jammulinksnews.com
Perspective Therapeutics to present updated data on cancer therapy at ESMO By Investing.com - Investing.com South Africa
Perspective Therapeutics Announces Acceptance of VMT-?-NET Data for Presentation at the ESMO Congress 2025 | CATX Stock News - GuruFocus
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ESMO Congress 2025 - The Globe and Mail
Major Breakthrough: Phase 2 NET Cancer Treatment Shows Mature Safety Data in 44 Patients, ESMO Preview - Stock Titan
Will Perspective Therapeutics Inc. stock benefit from interest rate changesUnmatched profit potential - jammulinksnews.com
Is Perspective Therapeutics Inc. a good long term investmentFree Investment Risk Control - Autocar Professional
What analysts say about Perspective Therapeutics Inc. stockUnmatched market performance - Autocar Professional
Perspective Therapeutics Inc. Stock Analysis and ForecastHigh-octane investment gains - Autocar Professional
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - MarketScreener
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - Benzinga
Why Perspective Therapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser
How Perspective Therapeutics Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
What makes Perspective Therapeutics Inc. stock price move sharplyHigh Return Setup Scanner - Newser
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results - The Manila Times
Cancer Treatment Pioneer Perspective Therapeutics Announces Q2 2025 Earnings Date: Key Updates Coming - Stock Titan
Top Reasons to Buy SBT(sbtcoin)Free Stock Market Practical Discussion Forums - newser.com
Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Perspective Therapeutics Inc (CATX Stock: A Sea of Opportunity - investchronicle.com
Perspective Therapeutics Updates Strategic Focus on Radiopharmaceuticals - TipRanks
Perspective Therapeutics, Inc.(NYSEAM: CATX) dropped from Russell 3000 Growth Index - MarketScreener
Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Vertex Pharmaceuticals (VRTX) and Edgewise Therapeutics (EWTX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail
Perspective Therapeutics (CATX) Maintains 'Outperform' Rating by Wedbush | CATX Stock News - GuruFocus
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial - Yahoo Finance
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - Finansavisen
0.03%
0.79%
자본화:
|
볼륨(24시간):